Search results
Asthma Triggers In Homes Can Send Kids to the ER—This Organization Is Working to Change That
Health.com· 4 days agoFor parents of children with asthma, witnessing an attack of severe symptoms can be a terrifying...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 4 days agoHEALTH NEWS GSK’s experimental drug for asthma met its goals in the latest trial, moving a treatment...
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Benzinga via AOL· 3 days agoWednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in...
Manage Your Asthma: FDA on Know Your Triggers and Treatment Options
Sierra Sun Times· 4 days agoAsthma is a chronic lung disease that causes the airways to become inflamed and narrow. Symptoms of...
Eosinophilic Asthma
Health via Yahoo News· 6 days agoConsider the following: Being 35-50 years old Having a personal or family history of asthma or other allergic conditions Smoking tobacco Diagnosis If you...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 4 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena via Yahoo Finance· 2 days agotreatment-emergent adverse event (TEAE), with a higher incidence in the rilzabrutinib group versus...
Northeast Ohio Black Health Coalition promotes air quality and asthma awareness
WFMJ Youngstown· 13 hours agoThose who suffer from asthma attacks know an attack can be severe, or even fatal. But not everyone...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 3 days agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 4 days agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a ...
